It is characterized by a lack of estrogen receptors (ER), progesterone receptors (PR) and epidermal growth factor receptor 2 (HER2/ErbB2), therefore, no targeted therapies against these proteins are useful to treat this carcinoma [1]. The gene discussed is ERBB2; the disease is carcinoma.